- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Ecolab Inc (ECL)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/09/2025: ECL (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $291.75
1 Year Target Price $291.75
| 8 | Strong Buy |
| 4 | Buy |
| 13 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 32.53% | Avg. Invested days 59 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 72.93B USD | Price to earnings Ratio 37.05 | 1Y Target Price 291.75 |
Price to earnings Ratio 37.05 | 1Y Target Price 291.75 | ||
Volume (30-day avg) 26 | Beta 0.98 | 52 Weeks Range 220.55 - 285.35 | Updated Date 12/8/2025 |
52 Weeks Range 220.55 - 285.35 | Updated Date 12/8/2025 | ||
Dividends yield (FY) 1.00% | Basic EPS (TTM) 6.94 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 12.49% | Operating Margin (TTM) 14.72% |
Management Effectiveness
Return on Assets (TTM) 7.75% | Return on Equity (TTM) 21.87% |
Valuation
Trailing PE 37.05 | Forward PE 32.26 | Enterprise Value 79708248168 | Price to Sales(TTM) 4.59 |
Enterprise Value 79708248168 | Price to Sales(TTM) 4.59 | ||
Enterprise Value to Revenue 5.06 | Enterprise Value to EBITDA 21.85 | Shares Outstanding 283235653 | Shares Floating 285362220 |
Shares Outstanding 283235653 | Shares Floating 285362220 | ||
Percent Insiders 0.16 | Percent Institutions 92.76 |
Upturn AI SWOT
Ecolab Inc

Company Overview
History and Background
Ecolab Inc. was founded in 1923 by Merritt J. Osborn in St. Paul, Minnesota, as Economics Laboratory. Initially focused on selling a single product, 'Absorbit,' a carpet cleaner, the company rapidly expanded its offerings and reach. A key milestone was the development of automated dispensing systems for cleaning and sanitizing products. Over the decades, Ecolab has grown through organic expansion and strategic acquisitions, becoming a global leader in water, hygiene, and infection prevention solutions and services.
Core Business Areas
- Global Industrial: This segment provides water treatment, cleaning, and sanitizing solutions for industrial customers in sectors such as food and beverage, manufacturing, power generation, and mining. Services include water management, process efficiency improvements, and pest elimination.
- Global Institutional: This segment serves the food service, hospitality, and healthcare industries with cleaning, sanitizing, and infection prevention products and services. Offerings include dishwashing, laundry, warewashing, and facility hygiene solutions.
- Global Healthcare: This segment focuses on providing infection prevention solutions and services to hospitals and healthcare facilities worldwide, including surgical instrument cleaning, patient room disinfection, and hand hygiene programs.
- Other: This segment includes pest elimination services and other specialty products and services that do not fit into the main segments.
Leadership and Structure
Ecolab is led by a board of directors and an executive management team. The CEO oversees global operations, which are structured around the key business segments mentioned above. The company emphasizes a field-based sales and service model, with a large workforce dedicated to customer interaction and problem-solving.
Top Products and Market Share
Key Offerings
- Water Treatment Solutions: Ecolab offers a comprehensive suite of water treatment chemicals, equipment, and services designed to optimize water usage, improve efficiency, and ensure compliance in industrial settings. Competitors include Veolia Water Technologies, Suez Water Technologies & Solutions, and Nalco Water (an Ecolab company, but often cited as a distinct brand in specific market contexts).
- Cleaning and Sanitizing Programs: This includes a wide range of detergents, sanitizers, and dispensing systems for commercial kitchens, laundries, and healthcare facilities. Key competitors include Diversey Holdings, Ecolab's primary competitor in many institutional and healthcare segments, and other specialized cleaning chemical providers.
- Infection Prevention Solutions: Focuses on products and services for healthcare settings, including hand hygiene, surgical site preparation, and instrument reprocessing. Competitors include 3M, STERIS, and various other medical supply and infection control companies.
- Pest Elimination Services: Ecolab's Pest Elimination division provides integrated pest management solutions for commercial clients. Major competitors include Rentokil Initial, Rollins Inc. (Orkin), and Terminix.
Market Dynamics
Industry Overview
Ecolab operates in the essential services sector, encompassing water treatment, cleaning, sanitation, and infection prevention. This industry is characterized by a strong demand driven by public health concerns, regulatory compliance, and the need for operational efficiency in various businesses. Growth is influenced by global economic conditions, sustainability trends, and increasing awareness of hygiene and water scarcity.
Positioning
Ecolab is a global leader in its served markets, renowned for its extensive portfolio of science-based solutions, dedicated field sales and service force, and commitment to sustainability. Its competitive advantages lie in its broad customer base across diverse industries, its technological innovation, and its strong customer relationships built on trust and demonstrated value.
Total Addressable Market (TAM)
The global market for water treatment, cleaning, sanitation, and infection prevention solutions is estimated to be in the hundreds of billions of dollars. Ecolab is well-positioned to capture a significant portion of this TAM due to its comprehensive offerings, global reach, and strong brand reputation. Its diversified business model allows it to address multiple facets of customer needs within these broad market segments.
Upturn SWOT Analysis
Strengths
- Global market leadership in water, hygiene, and infection prevention.
- Diversified customer base across multiple industries and geographies.
- Strong research and development capabilities and commitment to innovation.
- Extensive field sales and service network providing localized expertise.
- Reputation for reliability and delivering measurable value to customers.
- Commitment to sustainability and helping customers achieve their environmental goals.
Weaknesses
- Reliance on economic cycles affecting customer spending.
- Intense competition in certain segments.
- Potential for supply chain disruptions impacting product availability.
- Complexity of managing a large, global operation.
Opportunities
- Growing demand for water management and conservation solutions.
- Increasing focus on public health and infection control post-pandemic.
- Expansion into emerging markets with growing industrial and institutional sectors.
- Leveraging digital technologies for enhanced customer service and data analytics.
- Strategic acquisitions to expand product portfolios or market reach.
Threats
- Global economic slowdowns or recessions.
- Increased regulatory scrutiny or changes in environmental laws.
- Raw material price volatility and availability.
- Intensifying competition from both large and small players.
- Geopolitical instability impacting international operations and supply chains.
Competitors and Market Share
Key Competitors
- Diversey Holdings (DSE)
- Rollins Inc. (ROL)
- STERIS plc (STE)
- 3M Company (MMM)
- Veolia Environnement S.A. (VEOE.PA - Global, but significant US presence)
- Suez S.A. (SEV.PA - Global, but significant US presence)
Competitive Landscape
Ecolab holds a dominant position in many of its core markets, particularly in industrial water treatment and institutional cleaning. Its key advantages include its scale, technological innovation, and extensive service network. Competitors vary by segment; for example, Rollins is a strong competitor in pest control, while STERIS is a significant player in healthcare infection prevention. Ecolab's breadth of offerings and integrated solutions are a significant differentiator.
Major Acquisitions
Purolite
- Year: 2021
- Acquisition Price (USD millions): 3500
- Strategic Rationale: To significantly expand Ecolab's presence in the life sciences and bioprocessing sectors, complementing its existing water and hygiene solutions with specialized resin technologies for critical applications in pharmaceuticals, food and beverage, and industrial processes.
Pest Control of West Africa (PCWA)
- Year: 2022
- Acquisition Price (USD millions):
- Strategic Rationale: To strengthen Ecolab's pest elimination business in a key growth region, expanding its service capabilities and customer base in West Africa.
Growth Trajectory and Initiatives
Historical Growth: Ecolab has experienced consistent historical growth, driven by its expansion into new markets, the introduction of innovative products, and strategic acquisitions. Its focus on essential services has provided resilience even during economic downturns.
Future Projections: Analyst projections typically anticipate continued mid-single-digit revenue growth for Ecolab, supported by global demand for its solutions, especially in water management and infection prevention. Profitability is expected to grow in line with revenue, with potential for margin expansion through operational efficiencies and value-added services.
Recent Initiatives: Recent initiatives have likely included investments in digital transformation to enhance customer experience and data analytics, continued focus on sustainability solutions, and potential acquisitions to strengthen its market position or enter new niches. The company is also likely focusing on addressing evolving customer needs in areas like food safety and outbreak prevention.
Summary
Ecolab Inc. is a robust leader in essential water, hygiene, and infection prevention solutions. Its diversified business, strong R&D, and extensive service network provide significant competitive advantages. The company demonstrates consistent financial performance and a commitment to shareholder returns. However, it faces threats from economic downturns and intense competition, necessitating continued innovation and strategic execution to maintain its strong market position.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Ecolab Inc. Official Investor Relations Website
- U.S. Securities and Exchange Commission (SEC) Filings (10-K, 10-Q)
- Reputable financial news outlets and data providers (e.g., Bloomberg, Refinitiv, Yahoo Finance)
- Industry research reports
Disclaimers:
This analysis is based on publicly available information and general market knowledge. Financial data and market share figures are estimates and subject to change. This response does not constitute financial advice. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ecolab Inc
Exchange NYSE | Headquaters Saint Paul, MN, United States | ||
IPO Launch date 1988-01-05 | CEO & Chairman of the Board Mr. Christophe Beck | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 48000 | Website https://www.ecolab.com |
Full time employees 48000 | Website https://www.ecolab.com | ||
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four reportable segments: Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, refining, pulp and paper, and petrochemical industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. The Global Healthcare & Life Sciences segment offers cleaning and sanitizing products, such as infection prevention, and end-to-end cleaning and contamination control solutions to the healthcare, personal care, and pharmaceutical industries under the Ecolab, Bioquell, Purolite, and Anios brand names. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

